Tighter restrictions on the use of placebos, more protections for vulnerable populations, and compensation and treatment for individuals harmed in clinical trials are among the recent draft changes made by the World Medical Association to the Helsinki Declaration on medical research. Among the changes are provisions saying that researchers can use placebos only when no other reasonable option is available and they can target vulnerable patient groups only when they are unable to employ non-vulnerable populations.

Full Story:

Related Summaries